
Adverse reactions reported with Ciprofloxacin are summarized in the table. In each frequency category, adverse reactions are presented in the order of severity. Frequencies are defined as Very common (≥1/10), Common (≥1/100 to <1/10), Uncommon (≥1/1000 to <1/100), Rare (≥1/10,000 to <1/1,000), and Very Rare (<1/10,000). If it cannot be estimated from the available data, the frequency is defined as Unknown. MedDRA terminology is used to describe specific reactions, their analogies, and related conditions. ADR terminology is based on MedDRA version 14.0 except for fungal infections and unidentified pains.
Following adverse reactions are added based on analysis and assessment of reported adverse reactions in Korea.
Skin: Maculopapule, Rash, Purpuric eruption.
Injection site: Rash, Pruritus, Urticaria.
View ADR Reporting Link